CN Patent

CN100363346C — 冠状病毒主蛋白酶的小分子抑制剂、制备方法及其应用

Assigned to Shanghai Institute of Organic Chemistry of CAS · Expires 2008-01-23 · 18y expired

What this patent protects

本发明提供了基于SARS冠状病毒主蛋白酶的晶体结构所设计的一系列小分子抑制剂，其结构通式如式(I)所示。本发明还提供了所述小分子抑制剂的制备方法，及其在制备用于治疗或者预防各种冠状病毒感染的药物中的用途。

USPTO Abstract

本发明提供了基于SARS冠状病毒主蛋白酶的晶体结构所设计的一系列小分子抑制剂，其结构通式如式(I)所示。本发明还提供了所述小分子抑制剂的制备方法，及其在制备用于治疗或者预防各种冠状病毒感染的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN100363346C
Jurisdiction
CN
Classification
—
Expires
2008-01-23
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Organic Chemistry of CAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.